nference, inc. — Form D
nference, inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-12. The offering totals $9.6M, of which $9.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-03-12
- Form: D
- Accession: 0001806274-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.6M
- Amount sold: $9.6M
- Investors: 57
- Date of first sale: 2020-03-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-362727
Issuer
- Name: nference, inc.
- CIK: 0001806274
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: ONE MAIN STREET, CAMBRIDGE, MA, 02142
- Phone: 781-341-0941
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Tim Barrows | Director | Boston, MA |
| Andrew Danielsen | Director | Cambridge, MA |
| Harris Fishman | Executive Officer | Cambridge, MA |
| Agustin Marquez | Executive Officer | Cambridge, MA |
| David Goel | Director | Portsmouth, NH |
| Murali Aravamudan | Director | Cambridge, MA |
| Murali Aravamudan | Executive Officer | Cambridge, MA |
| Thomas McNaughton | Executive Officer | Cambridge, MA |
| Venkataramanan Soundararajan | Executive Officer | Cambridge, MA |
| John Halamka | Director | Cambridge, MA |
| Ajit Rajasekharan | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More